Top Markets
Coin of the day
Aker BioMarine AS Aker BioMarine AS

Aker BioMarine AS

AKBM
株式のランク #8735
Aker BioMarine AS, a subsidiary of Aker ASA, is a Norwegian company established... Aker BioMarine AS, a subsidiary of Aker ASA, is a Norwegian company established in 2006 and headquartered in Lysaker. The firm is dedicated to the global development, production, and commercialization of ingredients sourced from krill, serving diverse applications in nutraceuticals, dietary supplements, and animal feed. Its market reach extends across Norway, the Americas, Asia Pacific, Europe, the Middle East, and Africa. The company operates through two distinct segments: Ingredients and Brands. Its product portfolio features Superba, a krill-derived nutraceutical ingredient recognized for its phospholipid complex containing choline, omega-3s, and astaxanthin. Other key offerings include QRILL Aqua, designed for aquaculture, and QRILL Pet, tailored for animal feed. Aker BioMarine also provides LYSOVETA, an innovative delivery platform based on LPC-bound EPA and DHA from krill, alongside INVI, a hydrolyzed protein isolate suitable for food and beverage applications. Beyond its core ingredient business, the company distributes natural supplements and various human health and nutrition products. Furthermore, it oversees AION, a circular solutions provider focused on waste recycling and material reuse.
株価
$13.48
最終同期: 2026-08-28
時価総額
$1.18B
変化(1日)
-0.92%
変化(1年)
59.71%
NO
取引 Aker BioMarine AS (AKBM)

カテゴリー

Aker BioMarine AS(AKBM)の収益
Aug 2026 時点の収益 TTM: 0
Aker BioMarine AS の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Aker BioMarine AS の収益履歴(2026 ~ 2026)
各年末の収益
収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差
$114.93B -
CH
- -
FR
- -
JP
$2.69B -
IN
- -
BR